BioCentury
ARTICLE | Financial News

Argos pulls IPO

March 7, 2012 1:42 AM UTC

Cancer immunotherapy company Argos Therapeutics Inc. (Durham, N.C.) withdrew its planned IPO citing market conditions. The company had planned to sell 5.3 million shares at $13-$15 per share. A $14 price would have raised $73.5 million and valued the company at $215.2 million. Argos filed to raise up to $86.3 million last July. ...